Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 16, 2008
Deterioration of quality of life of high-risk breast cancer patients treated with high-dose chemotherapy: the PEGASE 01 Quality of Life StudyPatricia Marino, Henri Roché, Pierre Biron, et al.
Journal of Gastrointestinal Oncology|November 30, 2017
Age and factors associated with access and time to post-operative adjuvant chemotherapy in colon cancer: a French epidemiological studyJean Capsec, Carole Lefebvre, Fabienne Chupé, et al.
Cancer Medicine|October 25, 2013
Management and outcome of 239 adolescent and adult rhabdomyosarcoma patientsSarah N Dumont, Dejka M Araujo, Mark F Munsell, et al.
Journal of Neuro-Oncology|January 14, 2009
Topotecan in combination with radiotherapy in unresectable glioblastoma: a phase 2 studyThierry Lesimple, Laurent Riffaud, Didier Frappaz, et al.
Clinical Lymphoma|January 11, 2003
Stage I-IIE primary non-Hodgkin's lymphoma of the testis: results of a prospective trial by the GOELAMS Study GroupClaude Linassier, Bernard Desablens, Thierry Lefrancq, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2005
Multicenter randomized phase II study of two schedules of docetaxel, estramustine, and prednisone versus mitoxantrone plus prednisone in patients with metastatic hormone-refractory prostate cancerStéphane Oudard, Eugeniu Banu, Philippe Beuzeboc, et al.
Pharmaceutics|February 25, 2023
Abigene, a Prospective, Multicentric Study of Abiraterone Acetate Pharmacogenetics in Metastatic Castration-Resistant Prostate CancerJean-Marc Ferrero, Hakim Mahammedi, Gwenaelle Gravis, et al.
International Journal of Cancer|January 19, 2007
Does high-dose carmustine increase overall survival in supratentorial high-grade malignant glioma? An EBMT retrospective studyJacques-Olivier Bay, Bay Jacques-Olivier, Claude Linassier, et al.
Cancer Treatment Reviews|September 26, 2016
Chemotherapy in hormone-sensitive metastatic prostate cancer: Evidences and uncertainties from the literatureGwenaëlle Gravis, François Audenet, Jacques Irani, et al.
Pageof 5